BioSpace News Archive

Business

Humanigen Reports Year-End 2021 Financial Results

Humanigen, Inc. today reported financial results for the year ended December 31, 2021, and announced corporate objectives for 2022.

February 28, 2022

·

9 min read

Lone Star Bio

Dr. Suhyun An introduces SVF adipose tissue stem cell therapy to the Campbell Medical Clinic in Houston, Texas

The Campbell Medical Clinic in Houston, Texas is one of the nation’s leading clinics in the field of regenerative medicine.

February 28, 2022

·

3 min read

Pharm Country

Patent Issued for Multiomic Approach to Autism Spectrum Disorder Diagnosis

Quadrant Biosciences Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued the company and its partners, the SUNY Research Foundation and Penn State Research Foundation, U.S Patent No. 11,242,563 (Analysis of Autism Spectrum Disorder).

February 28, 2022

·

4 min read

Genetown

Scipher Medicine to Participate in Truist Securities Life Sciences AI Symposium

Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced Chief Technology Officer Slava Akmaev, Ph.D., will participate in a virtual panel at the Truist Securities Life Sciences AI Symposium on Tuesday, March 1, 2022, at 10:10 a.m. ET.

February 28, 2022

·

1 min read

Drug Development

The National Science Foundation Awards Lura Health a $1M Phase II Small Business Innovation Research Grant

Lura Health, an innovative medical device company developing the first wearable salivary diagnostic health monitoring system, announced that the National Science Foundation has awarded the company a Phase II Small Business Innovation Research grant.

February 28, 2022

·

2 min read

Business

Altesa BioSciences Announces Scientific Advisory Board

Altesa BioSciences, Inc., a clinical-stage biopharmaceutical company developing and commercializing novel anti-viral drugs against common respiratory viruses and global viral threats, today announced the inaugural members of its Scientific Advisory Board (SAB).

February 28, 2022

·

3 min read

Global Kidney Function Test Market Size To Reach Usd 1,374.3 Million In 2030 - Rise In Demand For Technologically Advanced Diagnostic Machinery And Tools Is One Of The Key Factors Driving Market Revenue Growth Says Reports And Data

The global kidney function test market size is expected to reach USD 1,374.3 Million in 2030 and register a revenue CAGR of 6.5% during the forecast period, according to a latest report by Reports and Data.

February 28, 2022

·

6 min read

Global Cervical Cancer Diagnostics Market Size to Reach USD 12.69 Billion in 2030 - Government awareness programs on cervical cancer and mass procurement of testing kits for women are expected to drive market revenue growth says Reports and Data

The global cervical cancer diagnostics market size is expected to reach USD 12.69 Billion in 2030 and register a revenue CAGR of 5.8% over the forecast period, according to latest report by Reports and Data.

February 28, 2022

·

6 min read

Cancer Immunotherapy Market Growth – at a CAGR of 10.1% by 2028

Rising prevalence of different types of cancer and increasing government investments in R&D activities in the field of cancer immunotherapy are some of the major factors driving Cancer Immunotherapy market revenue growth.

February 28, 2022

·

7 min read

Metastatic Urothelial Carcinoma Market Growth – at a CAGR of 17.9% by 2028

Increasing geriatric population and rising prevalence of metastatic urothelial carcinoma worldwide are among the key factors driving the global Metastatic Urothelial Carcinoma market revenue growth.

February 28, 2022

·

7 min read